Tumor Lysis Syndrome - Toxicology

Relevant Publications

Tumor lysis syndrome in a patient with advanced lung squamous cell carcinoma undergoing combined therapy with a programmed cell death protein 1 inhibitor and first‑line chemotherapy: A case report.

Issue Release: 2024

Real-world incidence and prevention of tumor lysis syndrome in chronic lymphocytic leukemia treated with venetoclax.

Issue Release: 2024

Prevalence and risk factors for hyperuricemia and hyperuricosuria in patients with hematologic malignancies.

Issue Release: 2024

Tumor lysis syndrome following letrozole for locally advanced breast cancer: a case report.

Issue Release: 2024

A Study to Evaluate the Effectiveness and Safety of Prephase Steroid Treatment before Remission Induction Chemotherapy in Patients with Pediatric Acute Lymphoblastic Leukemia Using Common Data Model-Based Real-World Data: A Retrospective Observational Study.

Issue Release: 2024

Management and use of healthcare resources in patients with chronic lymphocytic leukemia initiating venetoclax in routine clinical practice.

Issue Release: 2024

A phase 3b study of venetoclax and azacitidine or decitabine in an outpatient setting in patients with acute myeloid leukemia.

Issue Release: 2024

Tumour lysis syndrome in a neonate with transient abnormal myelopoiesis.

Issue Release: 2024

Choriocarcinoma Syndrome: A Rare Complication\'s Impact on Metastatic Germ Cell Tumor Outcomes.

Issue Release: 2024

Severe labile hypertension in a patient with catecholamine-secreting neuroblastoma: a case report.

Issue Release: 2024

Extensive Intracranial Meningioma With Dehiscences: A Case Report.

Issue Release: 2024

Aggressive NK-cell Leukemia: A Case Report and Literature Review.

Issue Release: 2024

Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid Malignancies.

Issue Release: 2024

T-cell Acute Lymphoblastic Leukemia in Crisis: Hyperleukocytosis, Tumor Lysis Syndrome, and Innovative Approaches.

Issue Release: 2024

Pitfalls of Current Diagnostic Criteria of Tumor Lysis Syndrome.

Issue Release: 2024

Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis.

Issue Release: 2024

Tumor Lysis Syndrome in a Patient with BRAF Mutated Colon Cancer Treated with Cetuximab and Encorafenib.

Issue Release: 2024

A PHASE 1 FIRST-IN-HUMAN STUDY OF THE MCL-1 INHIBITOR AZD5991 IN PATIENTS WITH RELAPSED/REFRACTORY HEMATOLOGIC MALIGNANCIES.

Issue Release: 2024

Assessing the risk of tumor lysis syndrome associated with the use of antineoplastic agents: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database.

Issue Release: 2024

Improving cell reinfusion to enhance the efficacy of chimeric antigen receptor T-cell therapy and alleviate complications.

Issue Release: 2024

What are the Challenges of Implementing Annex VI?

How Can We Improve Ecosystem Health?

What Are the Applications in Toxicology?

Are there any alternatives to Deferoxamine?

How is Opioid Receptor Antagonism Used in Treatment?

How Can Individuals Protect Themselves from Toxicological Assaults?

How is Redness Diagnosed in Toxicology?

How is Functional Impairment Measured?

How Does the Use of Cleaner Fuels Affect Toxicology in Occupational Settings?

What are Toxicokinetic Studies?

Tumor Lysis Syndrome - Toxicology

Relevant Publications

Partnered Content Networks

Relevant Topics